var data={"title":"Ketoconazole (topical): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Ketoconazole (topical): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/389798?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=ketoconazole-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Ketoconazole (topical): Patient drug information \t&quot;</a> and <a href=\"topic.htm?path=ketoconazole-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Ketoconazole (topical): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120613\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Extina;</li>\n      <li>Ketodan [DSC];</li>\n      <li>Nizoral;</li>\n      <li>Nizoral A-D [OTC];</li>\n      <li>Xolegel</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120614\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Ketoderm;</li>\n      <li>Nizoral</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120619\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antifungal Agent, Imidazole Derivative;</li>\n      <li>\n        Antifungal Agent, Topical</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120753\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Cutaneous candidiasis:</b>  Topical: Cream: Apply once daily to cover the affected and immediate surrounding area for 2 weeks. <b>Note:</b> Canadian labeling recommends a duration of 2 to 3 weeks.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dandruff:</b>  Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Shampoo 1% (OTC labeling): Apply to wet hair, lather, and rinse thoroughly; repeat. Use every 3 to 4 days for up to 8 weeks; then apply only as needed to control dandruff.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Shampoo 2% (Canadian product only): Apply 5 to 10 mL to wet scalp, lather, leave on 3 to 5 minutes, and rinse; apply once every 1 to 2 weeks (prophylaxis) or twice weekly for 2 to 4 weeks (treatment).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Seborrheic dermatitis:</b>  Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream: Apply to the affected area twice daily for 4 weeks or until clinical response is noted</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Foam: Apply to affected area twice daily for 4 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gel: Apply to the affected area once daily for 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Shampoo 2% (Canadian product only; OTC labeling): Apply 5 to 10 mL to wet scalp, lather, leave on 3 to 5 minutes, and rinse; apply twice weekly for 2 to 4 weeks. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Tinea corporis, tinea cruris, tinea pedis:</b>  Topical: Cream: Apply to the affected and immediate surrounding area once daily. </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duration of treatment:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">US labeling: Tinea corporis, cruris: 2 weeks; tinea pedis: 6 weeks.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Canadian labeling: Tinea corporis: 3 to 4 weeks; tinea cruris: 2 to 4 weeks; tinea pedis: 4 to 6 weeks.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Tinea versicolor:</b>  Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream: Apply once daily to cover the affected and immediate surrounding area for 2 weeks. <b>Note:</b> Canadian labeling recommends a duration of 2 to 3 weeks.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Shampoo 2%: Apply to affected area of damp skin, lather, leave on 5 minutes, and rinse (one application is usually sufficient) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Susceptible fungal infections in the oral cavity (candidiasis, oral thrush, and chronic mucocutaneous candidiasis) (off-label use):</b>  Topical: Cream: Apply locally as directed with a thin coat to inner surface of denture and affected areas after meals</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120752\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=ketoconazole-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Ketoconazole (topical): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dandruff:</b>  Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Shampoo 1% (OTC labeling): Children &ge;12 years and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Shampoo 2% (Canadian product only): Children &gt;12 years and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Seborrheic dermatitis:</b>   Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Foam, gel: Children &ge;12 years and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Shampoo 2% (Canadian product only): Children &gt;12 years and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120754\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46307069\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46307070\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120805\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (15 g, 30 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Foam, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Extina: 2% (50 g, 100 g) [contains alcohol, usp, cetyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ketodan: 2% (100 g [DSC]) [contains alcohol, usp, cetyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (50 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Xolegel: 2% (45 g) [contains alcohol, usp, fd&amp;c yellow #10 (quinoline yellow), fd&amp;c yellow #6 (sunset yellow), propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ketodan: 2% [DSC] [contains cetyl alcohol, edetate disodium, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Shampoo, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Nizoral: 2% (120 mL) [contains fd&amp;c red #40]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Nizoral A-D: 1% (125 mL, 200 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (120 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120615\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120771\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Topical: For external use only; not for ophthalmic, oral, or intravaginal use. Avoid contact with the eyes and other mucous membranes. Wash hands after application.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cream: Apply to the affected and immediate surrounding area.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">Foam: Dispense foam into the cap of the can or other cool surface; do not dispense directly onto hands (foam will begin to melt upon contact with warm skin). Pick up small amounts of foam with the fingertips and gently massage into the affected area until the foam disappears. For hair-bearing areas, part the hair so that foam may be applied directly to the skin (rather than on the hair). Avoid exposure to flame or smoking during and immediately following application. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">Gel: Apply a thin layer to affected area with fingertips. Do not wash affected area for at least 3 hours after application; wait at least 20 minutes after gel application before applying makeup or sunscreen to the treated areas.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">Shampoo:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Thoroughly wet affected area, apply shampoo, lather generously, and rinse thoroughly; the Canadian labeling recommends leaving on for 3 to 5 minutes before rinsing. Do not use on areas that are broken or inflamed.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">For tinea versicolor, apply shampoo to damp skin of the affected area; leave on skin for 5 minutes before rinsing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120656\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream:</b> Treatment of tinea corporis (ringworm), tinea cruris (jock itch), and tinea pedis (athlete's foot) caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, and <i>Epidermophyton floccosum</i>; treatment of tinea (pityriasis) versicolor caused by <i>Pityrosporum orbiculare</i> (also known as <i>Malassezia furfur</i>); treatment of cutaneous candidiasis caused by <i>Candida</i> sp; treatment of seborrheic dermatitis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam, gel:</b> Treatment of seborrheic dermatitis in immunocompetent adults and children 12 years and older</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Limitations of use: Safety and efficacy for the treatment of fungal infections have not been established.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Shampoo:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">US labeling: Treatment of tinea versicolor caused by or presumed to be caused by <i>P. orbiculare</i> (<i>M. furfur</i> or <i>Malassezia orbiculare</i>)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Canadian labeling: Treatment and prophylaxis of conditions caused by <i>Pityrosporum</i> (eg, pityriasis capitis [dandruff]); treatment of seborrheic dermatitis</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">OTC labeling: Controls flaking, scaling, and itching associated with dandruff</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25726702\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Cream: Susceptible fungal infections in the oral cavity including candidiasis, oral thrush, and chronic mucocutaneous candidiasis</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120604\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Nizoral may be confused with Nasarel, Neoral, Nitrol</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120673\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Topical cream/gel:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Central nervous system: Localized burning (4%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Stinging of the skin (5%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Frequency not defined:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Central nervous system: Dizziness, headache, pain, paresthesia</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Acne vulgaris, erythema, facial swelling, impetigo, nail discoloration, pruritus, pustules, pyogenic granuloma, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hypersensitivity: Hypersensitivity reaction, contact dermatitis (possibly related to sulfites or propylene glycol)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Application site discharge, local irritation (severe)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ophthalmic: Eye irritation, keratoconjunctivitis sicca, swelling of eye</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Topical foam:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">1% to 10%: Local: Application site burning (10%), application site reaction (6%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Frequency not defined: Dermatologic: Contact dermatitis, erythema, pruritus, skin rash, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Shampoo:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Pruritus (&le;3%), xeroderma (&le;3%), abnormal hair texture (&lt;1%), loss of scalp hair (&lt;1%), scalp pustules (&lt;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Application site reaction (&le;3%), local irritation (&lt;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Frequency not defined:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Central nervous system: Burning sensation</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Alopecia, dry hair, hair discoloration, oily hair, skin rash, urticaria</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hypersensitivity: Anaphylaxis, angioedema, hypersensitivity reaction</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120663\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity to ketoconazole or any component of the formulation.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">OTC labeling: When used for self-medication, do not use on scalp that is broken or inflamed.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Documentation of allergenic cross-reactivity for azole antifungals is limited. However, because of similarities in chemical structure and/or pharmacologic actions, the possibility of cross-sensitivity cannot be ruled out with certainty.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120664\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypersensitivity reactions: Severe hypersensitivity reactions, including contact sensitization, photoallergenicity, and anaphylaxis (rare) have been reported; discontinue use if hypersensitivity occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Irritation: May cause irritation at the site of application; discontinue use if irritation occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Foam: Formulation contains alcohol and propane/butane; do not expose to open flame and/or smoking during or immediately after application. Do not puncture and/or incinerate container.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Gel: Flammable; avoid exposure to fire, flames, or smoking during or immediately after application.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Shampoo: Use may remove curl from permanently wavy hair, cause hair discoloration, and changes in hair texture.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Sulfites: Some dosage forms contain sulfites which may cause allergic-type reactions (including anaphylaxis) as well as life-threatening or less severe asthmatic episodes in certain individuals.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate use: Avoid contact with the eyes and other mucous membranes. Not for ophthalmic, oral, or intravaginal use. If condition worsens or does not improve after the treatment period, discontinue use and contact health care provider.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299555\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120700\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9150&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120659\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120660\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have been observed in animal reproduction studies with oral ketoconazole.  Ketoconazole is not detectable in the plasma following chronic use of the shampoo. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9771736\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Ketoconazole has been detected in breast milk following oral dosing. Although it is not detected in the plasma following chronic use of the shampoo, and concentrations in the plasma following application of the gel are &lt;250 times those observed with oral dosing, the manufacturers recommend that caution be used when administering ketoconazole to nursing women.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120707\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Alters the permeability of the cell wall by blocking fungal cytochrome P450; inhibits biosynthesis of triglycerides and phospholipids by fungi; inhibits several fungal enzymes that results in a build-up of toxic concentrations of hydrogen peroxide; also inhibits androgen synthesis</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120709\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Shampoo: None; Cream, Foam, Gel: Minimal</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8120807\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Ketoconazole External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (60 g): $276.96</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Extina External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (50 g): $941.96</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Ketoconazole External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (50 g): $708.36</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Xolegel External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (45 g): $815.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Shampoo</b> (Ketoconazole External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (120 mL): $27.75</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Shampoo</b> (Nizoral A-D External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (125 mL): $9.74</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Shampoo</b> (Nizoral External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (120 mL): $80.17</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10961983\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Amfazol (VN);</li>\n      <li>Apodruff (IN);</li>\n      <li>Aquarius (GR);</li>\n      <li>Arcolane (CO);</li>\n      <li>DaktaGOLD (AU, NZ);</li>\n      <li>Danfree (BD);</li>\n      <li>Dangel (LK);</li>\n      <li>Dermatin (MT);</li>\n      <li>Dermazol (UA);</li>\n      <li>Dermazole (PH);</li>\n      <li>Dezor (ID);</li>\n      <li>Dezor Cream (MY, SG, TH);</li>\n      <li>Dezor Kem (VN);</li>\n      <li>Dezor Shampoo (MY, PH);</li>\n      <li>Diazon (MY);</li>\n      <li>Faction (BR);</li>\n      <li>Fitonal (AR);</li>\n      <li>Formyco (ID, SG);</li>\n      <li>Fundan (SE);</li>\n      <li>Fungarest (ES);</li>\n      <li>Fungaway (TW);</li>\n      <li>Fungiderm-K (TH);</li>\n      <li>Fungium (CL, PY);</li>\n      <li>Fungoral (IS, LV, NO);</li>\n      <li>Kenazole (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, TW, YE);</li>\n      <li>Ketazol (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Ketoco (TW);</li>\n      <li>Ketoconazol (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Ketoderm (FR, QA);</li>\n      <li>Ketogin (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Ketoisdin (ES);</li>\n      <li>Ketona (TW);</li>\n      <li>Ketopine (NZ);</li>\n      <li>Ketozol (PH);</li>\n      <li>Ketozol Shampoo (IL);</li>\n      <li>Kezon (TH);</li>\n      <li>Larry (TH);</li>\n      <li>Micoral (AR, BR);</li>\n      <li>Micosin (EC);</li>\n      <li>Mikanisal (LV);</li>\n      <li>Mycofebrin (GR);</li>\n      <li>Mycoral (LK);</li>\n      <li>Nazole (KR);</li>\n      <li>Niz Creme (ZA);</li>\n      <li>Niz Shampoo (ZA);</li>\n      <li>Nizoral (AE, AT, BB, BD, BE, BF, BG, BH, BJ, BM, BS, CH, CI, CN, CY, CZ, DE, DK, EE, EG, ET, FI, GH, GM, GN, GY, HK, ID, IE, IL, IQ, IR, IT, JM, JO, KE, KW, LB, LR, LT, LU, LV, LY, MA, ML, MR, MT, MU, MW, MY, NE, NG, NL, OM, PH, PK, PL, PR, QA, RO, RU, SA, SC, SD, SG, SK, SL, SN, SR, SY, TH, TN, TR, TT, TZ, UA, UG, UY, VE, VN, YE, ZA, ZM, ZW);</li>\n      <li>Nizoral 2% Cream (NZ, PH);</li>\n      <li>Nizoral Cream (GB, IE);</li>\n      <li>Nizoral Shampoo (DE, NZ, PH);</li>\n      <li>Oronazol (HR);</li>\n      <li>Panfungol (ES);</li>\n      <li>Pikangwang (CN);</li>\n      <li>Pranzole (ET);</li>\n      <li>Pristine (HK, MY);</li>\n      <li>Pristinex (HK);</li>\n      <li>Reduff (PH);</li>\n      <li>Resolve (BD);</li>\n      <li>Sebizole (AU, LK, NZ);</li>\n      <li>Sporaxyl (TH);</li>\n      <li>Sporium (CO);</li>\n      <li>Terzolin (DE);</li>\n      <li>Triatop Lotion (CN);</li>\n      <li>Yucomy (MY, VN);</li>\n      <li>Zhoulixin (CN);</li>\n      <li>Zinoral (ZW)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Extina (ketoconazole foam) [prescribing information]. Newtown, PA: Prestium Pharma; June 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ketoconazole Cream [prescribing information]. Melville, NY: Fougera; May 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ketodan (ketoconazole foam) [prescribing information]. Allegan, MI: Perrigo; November 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ketoderm (ketoconazole cream) [product monograph]. Brampton, Ontario: TaroPharma; September 2003.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Moretti ME, Ito S, and Koren G, &ldquo;Disposition of Maternal Ketoconazole in Breast Milk,&rdquo; <i>Am J Obstet Gynecol</i>, 1995, 173(5):1625-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/ketoconazole-topical-drug-information/abstract-text/7503214/pubmed\" target=\"_blank\" id=\"7503214\">7503214</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Nizoral (ketoconazole shampoo) [prescribing information]. Titusville, NJ: Janssen; October 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Nizoral (ketoconazole shampoo) [product monograph]. Markham, Ontario: Johnson &amp; Johnson; October 2010.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Nizoral A-D (ketoconazole shampoo) [prescribing information]. Fort Washington, PA: McNeil; December 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Xolegel (ketoconazole gel) [prescribing information]. San Antonio, TX: DPT Laboratories; May 2012.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9150 Version 151.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F8120613\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F8120614\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F8120619\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F8120753\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F8120752\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F8120754\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F46307069\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F46307070\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F8120805\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F8120615\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F8120771\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F8120656\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25726702\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F8120604\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F8120673\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F8120663\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F8120664\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299555\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F8120700\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F8120659\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F8120660\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F9771736\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F8120707\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F8120709\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F8120807\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F10961983\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9150|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=ketoconazole-topical-patient-drug-information\" class=\"drug drug_patient\">Ketoconazole (topical): Patient drug information \t</a></li><li><a href=\"topic.htm?path=ketoconazole-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">Ketoconazole (topical): Pediatric drug information</a></li></ul></div></div>","javascript":null}